Christopher T. Giordano
2023
In 2023, Christopher T. Giordano earned a total compensation of $644.8K as President and Chief Executive Officer at Tenax Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,650 |
|---|---|
| Salary | $405,300 |
| Other | $36,820 |
| Total | $644,770 |
Giordano received $405.3K in salary, accounting for 63% of the total pay in 2023.
Giordano also received $202.7K in non-equity incentive plan and $36.8K in other compensation.
Rankings
In 2023, Christopher T. Giordano's compensation ranked 1,711th out of 2,918 executives tracked by ExecPay. In other words, Giordano earned more than 41.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,711 out of 2,918 | 41st |
Division Manufacturing | 1,002 out of 1,608 | 38th |
Major group Chemicals And Allied Products | 633 out of 901 | 30th |
Industry group Drugs | 617 out of 864 | 29th |
Industry Pharmaceutical Preparations | 441 out of 622 | 29th |
Source: SEC filing on September 27, 2024.
Giordano's colleagues
We found two more compensation records of executives who worked with Christopher T. Giordano at Tenax Therapeutics in 2023.